Skip to content

Fulgent Genetics

US · FLGT #3667 by market cap Listed 2016
24.12 -0.66 -2.66%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
D
Momentum strategy signal
Sell
Analyst consensus
Hold

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 1 analysts

Hold
Avg price target 19.00 -21.2%
Price target rangecurrent 24.12
Low19.00
Avg19.00
High19.00
Buy 0% Hold 100% Sell 0%
Recent ratings (5)
DateFirmAnalystRatingTarget
2026-11-06 Piper Sandler -- Hold 19.00
2026-08-04 Piper Sandler -- Hold 19.00
2026-03-02 UBS -- Buy 22.00
2025-11-11 Piper Sandler -- Hold 30.00
2025-11-10 UBS -- Buy 35.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-05 After close ±18.92% +27.22% (beat)
2026/Q2 2026-07-30 After close ±12.18% -18.11% (beat)
2026/Q1 2026-05-01 -- ±15.71% -6.98% (in line)
2025/Q4 2026-02-27 -- ±10.23% -38.09% (beat)
2025/Q3 2025-11-07 -- ±6.56% +18.15% (beat)
2025/Q2 2025-08-01 -- ±11.94% +7.86% (in line)
2025/Q1 2025-05-02 -- ±10.72% +19.07% (beat)
2024/Q4 2025-02-28 -- ±13.70% -1.53% (in line)
2024/Q3 2024-11-08 -- ±15.38% -11.76% (in line)
2024/Q2 2024-08-02 -- ±14.39% +6.32% (in line)
2024/Q1 2024-05-03 -- ±12.55% +1.22% (in line)
2023/Q4 2024-02-28 -- ±12.17% -8.14% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Fulgent Genetics discussion 0 comments

Add a comment